When treating patients with cardiovascular conditions, explains David May, MD, PhD, FACC, physicians should consider a variety of factors, both provider- and patient-related, that may impact transitions of care after a serious cardiovascular event. Understanding these factors can help physicians to aid their patients in navigating through healthcare transitions.
Dr May explains that it is the responsibility of the provider to educate patients and their families about the disease process, the purpose of medications, and the importance of adherence to the medication regimen.
Dr May emphasizes that it is important to help patients and their family members be contributing members of the care team, especially after the patient returns home.
In addition to provider-related factors, Dr May discusses patient-related factors that physicians should consider in helping patients experiencing transitions of care. Specifically, Dr May explains that psychosocial factors may play a role in the period immediately after an event has occurred; for example, patients may experience fear and/or anxiety.
Additionally, Dr May highlights some of the more common physical and economic factors. For example, he notes that forgetfulness may impact patients’ adherence to medication and that insurance requirements/paperwork may be challenging for patients to work through. These factors may cause great anxiety, and Dr May suggests that help with these issues should be provided to patients and families following a serious cardiovascular event.
Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD
April 8th 2025Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD
April 8th 2025Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
2 Commerce Drive
Cranbury, NJ 08512